Different dynamics of NLRP3 inflammasome-mediated IL‑1β production in GM-CSF– and M-CSF–differentiated human macrophages

Marietta Margit Budai, J. Tőzsér, Sz. Benkő

Research output: Article

6 Citations (Scopus)

Abstract

IL-1β is a “master” cytokine regulating a wide variety of physiologic and immunologic processes. The most frequently studied models for NLRP3 inflammasomemediated IL-1β production are the macrophages; however, depending on their microenvironment, they can develop into functionally different cells. Several protocols have been developed to model the diversity of these cells in vitro. Here, we report for the first time, to our knowledge, a comparative study about the dynamics and molecularmechanisms of NLRP3 inflammasome priming and activation in LPS-stimulated, human, monocytederived GM- or M-macrophages, differentiated in the presence of GM-CSF or M-CSF, respectively. Our results show that IL-1β production by LPS-stimulated M-macrophages is a rapid and short event that requires ATP supplementation and is attenuated, in part, by the presence of IL-10, which reduces Akt signaling. However, IL-1β production by GMmacrophages develops gradually, and these cells produce IL-1β, even in the absence of ATP supplementation, because of the constitutively active caspase-1 enzyme. We show that the membranebound ectonucleotidases have an important regulatory role on the IL-1β secretion in GM-macrophages. Furthermore, we provide evidence that adenosine treatment enhances LPS-primed IL-1β secretion by GM-macrophages, but not by M-macrophages. These results show that, because of the different activation status and expression levels of the NLRP3 inflammasome components, as well as the signaling activity of the pathways, the two subtypes of macrophages respond very differently to the same stimuli. For this reason, the molecular composition of the microenvironment that shapes macrophage development should be considered when research or therapeutic methods are planned to control IL-1β production.

Original languageEnglish
Pages (from-to)1335-1347
Number of pages13
JournalJournal of Leukocyte Biology
Volume101
Issue number6
DOIs
Publication statusPublished - jan. 1 2017

Fingerprint

Inflammasomes
Macrophage Colony-Stimulating Factor
Granulocyte-Macrophage Colony-Stimulating Factor
Interleukin-1
Macrophages
Adenosine Triphosphate
Therapeutic Human Experimentation
Caspase 1
Interleukin-10
Adenosine
Cytokines

ASJC Scopus subject areas

  • Immunology
  • Cell Biology

Cite this

@article{f6ffe5680f954feaaa4b3dd173654a24,
title = "Different dynamics of NLRP3 inflammasome-mediated IL‑1β production in GM-CSF– and M-CSF–differentiated human macrophages",
abstract = "IL-1β is a “master” cytokine regulating a wide variety of physiologic and immunologic processes. The most frequently studied models for NLRP3 inflammasomemediated IL-1β production are the macrophages; however, depending on their microenvironment, they can develop into functionally different cells. Several protocols have been developed to model the diversity of these cells in vitro. Here, we report for the first time, to our knowledge, a comparative study about the dynamics and molecularmechanisms of NLRP3 inflammasome priming and activation in LPS-stimulated, human, monocytederived GM- or M-macrophages, differentiated in the presence of GM-CSF or M-CSF, respectively. Our results show that IL-1β production by LPS-stimulated M-macrophages is a rapid and short event that requires ATP supplementation and is attenuated, in part, by the presence of IL-10, which reduces Akt signaling. However, IL-1β production by GMmacrophages develops gradually, and these cells produce IL-1β, even in the absence of ATP supplementation, because of the constitutively active caspase-1 enzyme. We show that the membranebound ectonucleotidases have an important regulatory role on the IL-1β secretion in GM-macrophages. Furthermore, we provide evidence that adenosine treatment enhances LPS-primed IL-1β secretion by GM-macrophages, but not by M-macrophages. These results show that, because of the different activation status and expression levels of the NLRP3 inflammasome components, as well as the signaling activity of the pathways, the two subtypes of macrophages respond very differently to the same stimuli. For this reason, the molecular composition of the microenvironment that shapes macrophage development should be considered when research or therapeutic methods are planned to control IL-1β production.",
keywords = "Adenosine, ATP, Caspase-1, Cytokines, Signaling",
author = "Budai, {Marietta Margit} and J. Tőzs{\'e}r and Sz. Benkő",
year = "2017",
month = "1",
day = "1",
doi = "10.1189/jlb.3A0716-300RR",
language = "English",
volume = "101",
pages = "1335--1347",
journal = "Journal of Leukocyte Biology",
issn = "0741-5400",
publisher = "FASEB",
number = "6",

}

TY - JOUR

T1 - Different dynamics of NLRP3 inflammasome-mediated IL‑1β production in GM-CSF– and M-CSF–differentiated human macrophages

AU - Budai, Marietta Margit

AU - Tőzsér, J.

AU - Benkő, Sz.

PY - 2017/1/1

Y1 - 2017/1/1

N2 - IL-1β is a “master” cytokine regulating a wide variety of physiologic and immunologic processes. The most frequently studied models for NLRP3 inflammasomemediated IL-1β production are the macrophages; however, depending on their microenvironment, they can develop into functionally different cells. Several protocols have been developed to model the diversity of these cells in vitro. Here, we report for the first time, to our knowledge, a comparative study about the dynamics and molecularmechanisms of NLRP3 inflammasome priming and activation in LPS-stimulated, human, monocytederived GM- or M-macrophages, differentiated in the presence of GM-CSF or M-CSF, respectively. Our results show that IL-1β production by LPS-stimulated M-macrophages is a rapid and short event that requires ATP supplementation and is attenuated, in part, by the presence of IL-10, which reduces Akt signaling. However, IL-1β production by GMmacrophages develops gradually, and these cells produce IL-1β, even in the absence of ATP supplementation, because of the constitutively active caspase-1 enzyme. We show that the membranebound ectonucleotidases have an important regulatory role on the IL-1β secretion in GM-macrophages. Furthermore, we provide evidence that adenosine treatment enhances LPS-primed IL-1β secretion by GM-macrophages, but not by M-macrophages. These results show that, because of the different activation status and expression levels of the NLRP3 inflammasome components, as well as the signaling activity of the pathways, the two subtypes of macrophages respond very differently to the same stimuli. For this reason, the molecular composition of the microenvironment that shapes macrophage development should be considered when research or therapeutic methods are planned to control IL-1β production.

AB - IL-1β is a “master” cytokine regulating a wide variety of physiologic and immunologic processes. The most frequently studied models for NLRP3 inflammasomemediated IL-1β production are the macrophages; however, depending on their microenvironment, they can develop into functionally different cells. Several protocols have been developed to model the diversity of these cells in vitro. Here, we report for the first time, to our knowledge, a comparative study about the dynamics and molecularmechanisms of NLRP3 inflammasome priming and activation in LPS-stimulated, human, monocytederived GM- or M-macrophages, differentiated in the presence of GM-CSF or M-CSF, respectively. Our results show that IL-1β production by LPS-stimulated M-macrophages is a rapid and short event that requires ATP supplementation and is attenuated, in part, by the presence of IL-10, which reduces Akt signaling. However, IL-1β production by GMmacrophages develops gradually, and these cells produce IL-1β, even in the absence of ATP supplementation, because of the constitutively active caspase-1 enzyme. We show that the membranebound ectonucleotidases have an important regulatory role on the IL-1β secretion in GM-macrophages. Furthermore, we provide evidence that adenosine treatment enhances LPS-primed IL-1β secretion by GM-macrophages, but not by M-macrophages. These results show that, because of the different activation status and expression levels of the NLRP3 inflammasome components, as well as the signaling activity of the pathways, the two subtypes of macrophages respond very differently to the same stimuli. For this reason, the molecular composition of the microenvironment that shapes macrophage development should be considered when research or therapeutic methods are planned to control IL-1β production.

KW - Adenosine

KW - ATP

KW - Caspase-1

KW - Cytokines

KW - Signaling

UR - http://www.scopus.com/inward/record.url?scp=85020235089&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85020235089&partnerID=8YFLogxK

U2 - 10.1189/jlb.3A0716-300RR

DO - 10.1189/jlb.3A0716-300RR

M3 - Article

C2 - 28232386

AN - SCOPUS:85020235089

VL - 101

SP - 1335

EP - 1347

JO - Journal of Leukocyte Biology

JF - Journal of Leukocyte Biology

SN - 0741-5400

IS - 6

ER -